HMG

Human Menopausal Gonadotropin. Contains both FSH and LH activity. Used for fertility restoration post-AAS, more effective than HCG alone for spermatogenesis.

Overview

Peptide

Human Menopausal Gonadotropin. Contains both FSH and LH activity. Used for fertility restoration post-AAS, more effective than HCG alone for spermatogenesis.

Effects on Markers

Directly stimulates FSH and LH receptors, promotes spermatogenesis (FSH component) and testosterone production (LH component), more effective than HCG alone for fertility recovery, can elevate estradiol

Compound Guide

Structure: Urinary-derived gonadotropin containing both FSH and LH in roughly equal proportions. Provides direct gonadotropin stimulation.

Dosage:

  • Fertility restoration: 75-150 IU every other day for 3-6 months
  • Combined with HCG: HCG 1000-1500 IU 2x/week + HMG 75 IU 3x/week
  • Aggressive protocol: HMG 150 IU EOD + HCG 1500 IU 2x/week

Administration:

  • IM or SubQ injection
  • Reconstitute with provided diluent or bacteriostatic water
  • Cycle length for fertility: 3-6 months minimum (spermatogenesis takes ~74 days per cycle)

Key Notes:

  • The FSH component is critical for spermatogenesis — HCG alone only provides LH activity
  • Gold standard for post-AAS fertility restoration when HCG alone is insufficient
  • Expensive — often reserved for when fertility is the primary goal
  • Semen analysis should be performed at baseline and every 2-3 months during treatment
  • Can elevate estradiol — monitor E2 and manage if symptomatic
  • Monitor: LH, FSH, testosterone, E2, semen analysis (count, motility, morphology)
  • Full fertility recovery can take 6-12+ months after prolonged AAS use

Usage History

Markers to Monitor

Frequently Asked Questions

Quick Reference

Category

Peptide

Half-Life

~24 hours

Detection Time

N/A

Usage Summary